Shareholder Vote

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________ FORM 8-K __________________ CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 10, 2022 __________________ DANAHER CORPORATION (Exact Name of Registrant as Specified in Its Charter) __________________ Delaware 001-08089 59-1995548 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) 2200 Pennsylvania Avenue, NW 20037-1701 Suite 800W Washington, DC (Address of Principal Executive Offices)   (Zip Code) 202 - 828-0850 (Registrant’s Telephone Number, Including Area Code) Not applicable (Former Name or Former Address, if Changed Since Last Report) __________________ Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below) : ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common stock, $0.01 par value DHR New York Stock Exchange 5.00% Mandatory Convertible Preferred Stock, Series B, without par value DHR.PRB New York Stock Exchange Floating Rate Senior Notes due 2022 DHR/22A New York Stock Exchange 1.700% Senior Notes due 2024 DHR 24 New York Stock Exchange 0.200% Senior Notes due 2026 DHR/26 New York Stock Exchange 2.100% Senior Notes due 2026 DHR 26 New York Stock Exchange 1.200% Senior Notes due 2027 DHR/27 New York Stock Exchange 0.450% Senior Notes due 2028 DHR/28 New York Stock Exchange 2.500% Senior Notes due 2030 DHR 30 New York Stock Exchange 0.750% Senior Notes due 2031 DHR/31 New York Stock Exchange 1.350% Senior Notes due 2039 DHR/39 New York Stock Exchange 1.800% Senior Notes due 2049 DHR/49 New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐  ITEM 5.07 SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS     The Company’s annual meeting of shareholders was held on May 10, 2022. At the annual meeting, the Company’s shareholders voted on the following proposals: 1.    To elect the thirteen directors named in the Company’s proxy statement to terms expiring in 2023. Each nominee for director was elected by a vote of the shareholders as follows: For Against Abstain Broker Non-Votes Rainer M. Blair 584,400,996  12,815,360  659,689  33,382,915  Linda Filler 489,079,141  107,647,340  1,149,564  33,382,915  Teri List 444,924,376  152,278,486  673,183  33,382,915  Walter G. Lohr, Jr. 405,844,176  191,353,475  678,394  33,382,915  Jessica L. Mega, MD, MPH 593,692,579  3,531,363  652,103  33,382,915  Mitchell P. Rales 579,632,770  17,577,041  666,234  33,382,915  Steven M. Rales 572,125,079  25,041,244  709,722  33,382,915  Pardis C. Sabeti, MD, D. Phil 594,117,808  3,091,884  666,353  33,382,915  A. Shane Sanders 454,786,279  142,399,273  690,493  33,382,915  John T. Schwieters 411,902,160  185,290,498  683,387  33,382,915  Alan G. Spoon 523,557,221  73,646,050  672,774  33,382,915  Raymond C. Stevens, PhD 590,048,862  7,144,222  682,961  33,382,915  Elias A. Zerhouni, MD 564,604,841  32,585,784  685,420  33,382,915  2.    To ratify the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2022. The proposal was approved by a vote of shareholders as follows: For 611,138,804  Against 19,138,122  Abstain 982,034  3.    To approve on an advisory basis the Company’s named executive officer compensation. The proposal was approved by a vote of shareholders as follows: For 561,170,146  Against 35,745,911  Abstain 959,988  Broker Non-Votes 33,382,915  4.    To act upon a shareholder proposal requesting that Danaher amend its governing documents to reduce the percentage of shares required for shareholders to call a special meeting of shareholders from 25% to 10% . The proposal was rejected by a vote of shareholders as follows: For 257,852,453  Against 339,026,638  Abstain 996,954  Broker Non-Votes 33,382,915  ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS (c) Exhibits: Exhibit No.    Description 104 Cover Page Interactive Data File (formatted as inline XBRL with applicable taxonomy extension information contained in Exhibits 101) SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. DANAHER CORPORATION Date: May 11, 2022 By: /s/ James F. O’Reilly James F. O’Reilly Vice President, Deputy General Counsel and Secretary